Cargando…

Extracellular HMGB1 Contributes to the Chronic Cardiac Allograft Vasculopathy/Fibrosis by Modulating TGF-β1 Signaling

Cardiac allograft vasculopathy (CAV) charactered with aberrant remodeling and fibrosis usually leads to the loss of graft after heart transplantation. Our previous work has reported that extracellular high-mobility group box 1 (HMGB1) participated in the CAV progression via promoting inflammatory ce...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zou, Huijuan, Ming, Bingxia, Li, Jun, Xiao, Yifan, Lai, Lin, Gao, Ming, Xu, Yong, Tan, Zheng, Gong, Feili, Zheng, Fang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7988222/ https://www.ncbi.nlm.nih.gov/pubmed/33777037 http://dx.doi.org/10.3389/fimmu.2021.641973

Ejemplares similares

The Role of HMGB1 in Rheumatic Diseases
por: Dong, Yuanji, et al.
Publicado: (2022)

Allograft or Recipient ST2 Deficiency Oppositely Affected Cardiac Allograft Vasculopathy via Differentially Altering Immune Cells Infiltration
por: Zhang, Zhenggang, et al.
Publicado: (2021)

Effects of mimicked acetylated HMGB1 on macrophages and dendritic cells
por: Chen, Xiaohong, et al.
Publicado: (2018)

HMGB1 Promotes the Release of Sonic Hedgehog From Astrocytes
por: Xiao, Yifan, et al.
Publicado: (2021)

Glycyrrhizin Protects Mice Against Experimental Autoimmune Encephalomyelitis by Inhibiting High-Mobility Group Box 1 (HMGB1) Expression and Neuronal HMGB1 Release
por: Sun, Yan, et al.
Publicado: (2018)

Down-regulation of nuclear HMGB1 reduces ischemia-induced HMGB1 translocation and release and protects against liver ischemia-reperfusion injury
por: Zhao, Guangyuan, et al.
Publicado: (2017)

Risk factors of cardiac allograft vasculopathy
por: Szyguła-Jurkiewicz, Bożena, et al.
Publicado: (2015)

HMGB1‐Promoted Neutrophil Extracellular Traps Contribute to Cardiac Diastolic Dysfunction in Mice
por: Zhang, Xin‐Lin, et al.
Publicado: (2022)

Melatonin Synergizes With Mesenchymal Stromal Cells Attenuates Chronic Allograft Vasculopathy
por: Qin, Ya-fei, et al.
Publicado: (2021)

Far-Infrared Therapy Decreases Orthotopic Allograft Transplantation Vasculopathy
por: Lin, Yi-Wen, et al.
Publicado: (2022)

Early Cardiac Allograft Vasculopathy: Are the Viruses to Blame?
por: Aggarwal, Ashim, et al.
Publicado: (2012)

Cardiac allograft vasculopathy: diagnosis, therapy, and prognosis
por: Skorić, Boško, et al.
Publicado: (2014)

Coronary CTA for Surveillance of Cardiac Allograft Vasculopathy
por: Shah, Nishant R., et al.
Publicado: (2018)

The role of everolimus in treatment of cardiac allograft vasculopathy
por: Watanabe, Tetsu
Publicado: (2013)

The novel proteomic signature for cardiac allograft vasculopathy
por: Wei, Dongmei, et al.
Publicado: (2022)

Corrigendum: Melatonin Synergizes With Mesenchymal Stromal Cells Attenuates Chronic Allograft Vasculopathy
por: Qin, Ya-fei, et al.
Publicado: (2021)

Contribution of TGF-Beta-Mediated NLRP3-HMGB1 Activation to Tubulointerstitial Fibrosis in Rat With Angiotensin II-Induced Chronic Kidney Disease
por: Zhang, Kaimin, et al.
Publicado: (2020)

Flt3L Combined with Rapamycin Promotes Cardiac Allograft Tolerance by Inducing Regulatory Dendritic Cells and Allograft Autophagy in Mice
por: Xiong, Ali, et al.
Publicado: (2012)

Expression and significance of HMGB1, TLR4 and NF-κB p65 in human epidermal tumors
por: Weng, Hui, et al.
Publicado: (2013)

What is the optimal prophylaxis for treatment of cardiac allograft vasculopathy?
por: Kobashigawa, Jon
Publicado: (2000)

Cardiac allograft vasculopathy in Dutch heart transplant recipients
por: Galli, G., et al.
Publicado: (2016)

Correction to: Coronary CTA for Surveillance of Cardiac Allograft Vasculopathy
por: Shah, Nishant R., et al.
Publicado: (2018)

Effect of Statin Intensity on the Progression of Cardiac Allograft Vasculopathy
por: Ellimuttil, Tracey M, et al.
Publicado: (2021)

HMGB1 and Extracellular Histones Significantly Contribute to Systemic Inflammation and Multiple Organ Failure in Acute Liver Failure
por: Yang, Runkuan, et al.
Publicado: (2017)

Multiparametric cardiovascular magnetic resonance assessment of cardiac allograft vasculopathy
por: Miller, Christopher A, et al.
Publicado: (2014)

A reproducible mouse model of chronic allograft nephropathy with vasculopathy
por: Zarjou, Abolfazl, et al.
Publicado: (2012)

Cardiac Allograft Vasculopathy: A Donor or Recipient Induced Pathology?
por: van den Hoogen, Patricia, et al.
Publicado: (2015)

Vascular rejection in cardiac allograft vasculopathy: Impact on graft survival
por: Nair, Nandini
Publicado: (2022)

Epicardial fat volume is related to the degree of cardiac allograft vasculopathy
por: Roest, Stefan, et al.
Publicado: (2022)

Factors associated with cardiac allograft vasculopathy after heart transplantation
por: Szczurek-Wasilewicz, Wioletta, et al.
Publicado: (2022)

Increase in Hypotonic Stress-Induced Endocytic Activity in Macrophages via ClC-3
por: Yan, Yutao, et al.
Publicado: (2014)

Extracellular HMGB1 as Inflammatory Mediator in the Progression of Mycoplasma Gallisepticum Infection
por: Wang, Yingjie, et al.
Publicado: (2022)

Metformin attenuates post‐epidural fibrosis by inhibiting the TGF‐β1/Smad3 and HMGB1/TLR4 signaling pathways
por: Song, Zeyuan, et al.
Publicado: (2021)

Interleukin 21 (IL-21) regulates chronic allograft vasculopathy (CAV) in murine heart allograft rejection
por: Khattar, Mithun, et al.
Publicado: (2019)

Neutrophil mediated smooth muscle cell loss precedes allograft vasculopathy
por: King, Chelsey L, et al.
Publicado: (2010)

Quantitative coronary computed tomography angiography for the detection of cardiac allograft vasculopathy
por: Foldyna, Borek, et al.
Publicado: (2020)

Pharmacological vs Exercise Stress Echocardiography for Detection of Cardiac Allograft Vasculopathy
por: Gebska, Milena A., et al.
Publicado: (2020)

Multiparametric Cardiac Magnetic Resonance Imaging for Diagnosing Cardiac Allograft Vasculopathy
por: Lee, Ji Won
Publicado: (2022)

Association between an elevated level of HMGB1 and non-small-cell lung cancer: a meta-analysis and literature review
por: Xia, Quansong, et al.
Publicado: (2016)

Extracellular HMGB1 interacts with RAGE and promotes chemoresistance in acute leukemia cells
por: Lai, Weixin, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_56t2gbr3vc3v1glakqhf2m0smg